Tag: audit trail

Validating Electronic Signatures Under Part 11 and Annex 11: What to Prove and How Step-by-Step Guide to Validating Electronic Signatures Under 21 CFR Part 11 and Annex 11 Electronic signatures are a foundational element of modern pharmaceutical manufacturing and regulatory compliance. Validating electronic signatures under 21 CFR Part 11 (US FDA regulation) and Annex 11…

Read More “Validating Electronic Signatures Under Part 11 and Annex 11: What to Prove and How” »

Configuring and Validating Audit Trails in Chromatography and LIMS Platforms Configuring and Validating Audit Trails in Chromatography and LIMS Platforms: A GMP Step-by-Step Guide Ensuring data integrity is paramount in pharmaceutical manufacturing and laboratory environments, particularly when working with chromatography systems and Laboratory Information Management Systems (LIMS). Regulatory bodies such as the US Food and…

Read More “Configuring and Validating Audit Trails in Chromatography and LIMS Platforms” »

User Access Management for Critical GMP Applications: Roles, Rights and Reviews User Access Management for Critical GMP Applications: Essential Roles, Rights, and Periodic Reviews Ensuring data integrity is a foundational pillar in pharmaceutical Good Manufacturing Practice (GMP) compliance. The increasing digitization of GMP applications and critical computerized systems has elevated the importance of robust user…

Read More “User Access Management for Critical GMP Applications: Roles, Rights and Reviews” »

Designing Periodic Data Integrity Health Checks and Internal DI Audits Implementing Effective Periodic Data Integrity Health Checks and Internal Data Integrity Audits in Pharma Data integrity is fundamental for ensuring the quality, safety, and efficacy of pharmaceutical products and compliance with global regulatory expectations. With the evolving digital environment and regulatory focus, such as the…

Read More “Designing Periodic Data Integrity Health Checks and Internal DI Audits” »

Training Operators and Analysts on Real-World Data Integrity Scenarios Step-by-Step Guide to Training Operators and Analysts on Real-World Data Integrity Scenarios Maintaining rigorous data integrity is a cornerstone of pharmaceutical Good Manufacturing Practice (GMP). Operators and analysts, as front-line contributors to manufacturing and quality control processes, must be proficient in recognizing and handling real-world data…

Read More “Training Operators and Analysts on Real-World Data Integrity Scenarios” »

How to Document a Data Integrity Investigation That Regulators Will Trust Step-by-Step Tutorial: Documenting a Data Integrity Investigation in Compliance with ALCOA+, 21 CFR Part 11, and Annex 11 Ensuring data integrity has become a cornerstone of pharmaceutical Good Manufacturing Practice (GMP) compliance across the United States, United Kingdom, and European Union. Regulatory expectations from…

Read More “How to Document a Data Integrity Investigation That Regulators Will Trust” »

Sampling, Weighing and Data Recording: Closing Common DI Gaps on the Shop Floor Sampling, Weighing and Data Recording: Closing Common Data Integrity Gaps on the Pharmaceutical Shop Floor Ensuring data integrity in pharmaceutical manufacturing is fundamental to compliant and safe production. Inaccuracy or incompleteness in sampling, weighing, and data recording processes can increase the risk…

Read More “Sampling, Weighing and Data Recording: Closing Common DI Gaps on the Shop Floor” »

Applying ALCOA+ Principles to Paper Records in High-Volume Operations Step-by-Step Guide to Applying ALCOA+ Principles to Paper Records in High-Volume Pharmaceutical Operations Maintaining robust data integrity is critical in pharmaceutical manufacturing and related operations. The regulatory expectations set forth by authorities such as the FDA, EMA, and MHRA emphasize adherence to ALCOA+ principles to ensure…

Read More “Applying ALCOA+ Principles to Paper Records in High-Volume Operations” »

Managing Hybrid Paper–Electronic Systems Without Compromising Data Integrity Step-by-Step Guide to Managing Hybrid Paper–Electronic Systems Without Compromising Data Integrity In the pharmaceutical industry, maintaining data integrity across all forms of recording media is critical to product quality, regulatory compliance, and patient safety. Hybrid paper–electronic systems—where both paper and electronic records coexist—remain prevalent in many pharmaceutical…

Read More “Managing Hybrid Paper–Electronic Systems Without Compromising Data Integrity” »

Data Integrity Remediation After an MHRA or FDA Inspection: Step-by-Step Approach Step-by-Step Guide to Data Integrity Remediation After an MHRA or FDA Inspection Ensuring robust data integrity is paramount for pharmaceutical manufacturers and related stakeholders in the United States, United Kingdom, and European Union. Regulatory authorities such as the FDA, MHRA, and EMA place significant…

Read More “Data Integrity Remediation After an MHRA or FDA Inspection: Step-by-Step Approach” »